In acute cerebral ischemia and stroke, PKCα functions as a central signaling hub, rapidly stimulating glutamate metabolism via the smoothened (SMO)–PKCα–GLT‐1 pathway, leading to neuronal excitotoxicity and cell death. The gene discussed is SLC1A2; the disease is stroke disorder.